The 2022 data reveals a positive trend with respect to the augmented quantity of early-stage clinical candidates as compared to 2019.
← all excerpts
Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections.
1
—
—